Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 4

Весенний сезон острых респираторных инфекций: что это означает для коморбидного пациента и как к нему подготовиться
В.Н. Шишкова

Список литературы

1. Rothberg MB, Haessler S, Brown RB. Complications of viral influenza. The American Journal of Medicine 2008 Apr;121(4):258-64.
2. World Health Organization. The world health report 2002 – reducing risks, promoting healthy life. Geneva, Switzerland: WHO; 2002: 186, 192.
3. Sellers SA, Hagan RS, Hayden FG, Fischer WA. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza and Other Respiratory Viruses 2017 Sep;11(5):372-93.
4. Xiong TY, Redwood S, Prendergast B, Chen M. Coronoviruses and the cardiovascular system: acute and long-term implications. The European Heart Journal 2020:EHAA23.
5. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiology 2016 Jun;1(3):274.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print].
7. Madjid M, Solomon SD, Vardeny O, Mullen B. Cardiac implications of coronavirus (COVID-19). Available from: https://www.acc.org/latest-in-cardiology/articles/2020/02/13/12/42/acc-clinical-bulletin-focuses-on-cardiac-implications-of-coronavirus-2019-ncov Accessed 2020 Feb 18.
8. Шишкова В.Н. Сахарный диабет как предрасполагающая к развитию респираторных заболеваний патология. Врач 2013;11:25-8.
9. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. 2015. Available from: www.idf.org/diabetesatlas Accessed 2019 Dec 12.
10. Муминов А.И., Хасанов С.А., Джаббаров Н.Д. Состояние ЛОР-органов у больных сахарным диабетом. Актуальные вопросы оториноларингологии. Ташкент, 1976: 96-7.
11. Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition? Treatment and prevention. John Hopkins. Advance Studies in Medicine 2006;6(2):71-81.
12. Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. The Journal of Laryngology & Otology 1989 Sep;103(9):853-5.
13. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987 Jul-Aug;10(4):483-6.
14. Tuazon CU. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. American Journal of Medicine 1984 May;76(5A):166-71.
15.Sreebny LM, Yu A, Green A, Valdini A. Xerostomia in diabetes mellitus. Diabetes Care 1992 Jul;15(7):900-4.
16. Chavez EM, Borrell LN, Taylor GW, Ship JA. Longitudinal analysis of salivary function in older diabetics and controls. Journal of Dental Research 2000;79(Spec):Abst.N.1878.
17. Муминов А.И., Шамирзоев Н.Х., Джаббаров Н.Д. Морфологические исследования слизистой оболочки носовой полости при сахарном диабете. Вестник oториноларингологии 1980;4:39-42.
18. Schaberg DS, Norwood JM. Case study: infections in diabetes mellitus. Diabetes Spectrum 2002 Jan;15(1):37-40.
19. Попов Н.Н., Гарюк Г.И., Филатова И.В., Огнивенко Е.В. Клинико-иммунологическая характеристика течения хронического гнойного верхнечелюстного синусита у больных сахарным диабетом. Международный медицинский журнал 2007;(1):103-7.
20. Китайгородский А.П. О положительном эффекте аденотонзиллэктомии у детей, больных хроническим тонзиллитом, аденоидитом и сахарным диабетом. Вестник оториноларингологии 1984;(3):34-8.
21. Шишкова В.Н. Рациональный подход к решению кардиометаболических проблем в терапии коморбидных пациентов. Врач 2018;11:3-11.
22. Kremerman IB, Priimiagi LS, Kalvinsh IIa, Lukevits EIa. Interferon-inducing and antiinfluenzal properties of 3-(2,2,2-trimethylhydrazine)propionate in an experiment. Voprosy Virusologii 1987 Sep-Oct;32(5):576-9.
23. Safonova IS, Dadalova AI, Shuturova NYu. Effect of mildronate used as an adjuvant on immune human system. Experimental and Clinical Pharmacotherapy (Riga) 1992;20:67-71.
24. Kubar OI, Bryantseva EA, Davydova TV, Furgai SM, Bubenyova TV, Kolltygina NV. Results of clinical trials of mildronate immuno-adjuvant action in vaccination with inactivated influenza vaccine. Experimental and Clinical Pharmacotherapy (Riga) 1992;20:72-5.
25. Glozman VN, Berenbein BA, Kirmane RE, Pervushina NV, Shur AA, Agranovskii VB. Use of mildronate in therapy of seroresistant syphilis (serologic and immunologic comparisons). Antibiotiki i Khimioterapiya 1991;36:38-9.
26. Nikolaeva IA, Prokopenko LG. Immunomodulating action of energizing drugs during dosed fasting. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya 1998 Jul-Sep;3:12-5.
27. Starchenko AA, Khilko VA, Gaidar BV, Khlunovskii AN, Komarets SA. Characteristics of adaptive reactions of the body’s immune system following operations for vascular anomalies. NN Burdenko Journal of Neurosurgery1995;4:13-6.
28. Orlov VA, Sokolova VI, Zamotaev IP, Elagina LV, Zavolovskaia LI. Clinicoimmunologic aspects of using mildronate in patients with bronchopulmonary diseases. Antibiotiki i Khimioterapiya 1990;35:47-50.
29. Karashurov E, Ostrovskij A, Klavinsh I. Treatment of bronchial asthma with mildronate. Experimental and Clinical Pharmacotherapy (Riga) 1991;19:172-8.
30. Sakharchuk II, Ilnytskiy RI. The use of mildronate and trental in treating disorders of hemorheology and the intracardiac hemodynamics in patients with chronic obstructive bronchitis. Likarska Sprava 1996 Jan-Feb;1-2:122-5.
31. Антоненко Л.И., Французова С.Б., Аршинникова Л.Л. Влияние милдроната на проницаемость эритроцитарных мембран при экспериментальной патологии легких. Экспериментальная и клиническая фармакология 1992;55:33-5.

References

1. Rothberg MB, Haessler S, Brown RB. Complications of viral influenza. The American Journal of Medicine 2008 Apr;121(4):258-64.
2. World Health Organization. The world health report 2002 – reducing risks, promoting healthy life. Geneva, Switzerland: WHO; 2002: 186, 192.
3. Sellers SA, Hagan RS, Hayden FG, Fischer WA. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza and Other Respiratory Viruses 2017 Sep;11(5):372-93.
4. Xiong TY, Redwood S, Prendergast B, Chen M. Coronoviruses and the cardiovascular system: acute and long-term implications. The European Heart Journal 2020:EHAA23.
5. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiology 2016 Jun;1(3):274.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print].
7. Madjid M, Solomon SD, Vardeny O, Mullen B. Cardiac implications of coronavirus (COVID-19). Available from: https://www.acc.org/latest-in-cardiology/articles/2020/02/13/12/42/acc-clinical-bulletin-focuses-on-cardiac-implications-of-coronavirus-2019-ncov Accessed 2020 Feb 18.
8. Shishkova VN. Diabetes mellitus as a pathology predisposing to development of respiratory diseases. Vrach 2013;11:25-8 (In Russian).
9. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. 2015. Available from: www.idf.org/diabetesatlas Accessed 2019 Dec 12.
10. Muminov AI, Hasanov SA, Jabbarov ND. The state of ENT organs in patients with diabetes mellitus. Advance issues of otorhinolaryngology. Tashkent, 1976: 96-7 (In Russian).
11. Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition? Treatment and prevention. John Hopkins Advance Studies in Medicine 2006;6(2):71-81.
12. Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. The Journal of Laryngology & Otology 1989 Sep;103(9):853-5.
13. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987 Jul-Aug;10(4):483-6.
14. Tuazon CU. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. American Journal of Medicine 1984 May;76(5A):166-71.
15.Sreebny LM, Yu A, Green A, Valdini A. Xerostomia in diabetes mellitus. Diabetes Care 1992 Jul;15(7):900-4.
16. Chavez EM, Borrell LN, Taylor GW, Ship JA. Longitudinal analysis of salivary function in older diabetics and controls. Journal of Dental Research 2000;79(Spec):Abst.N.1878.
17. Muminov AI, Shamirzoyev NKh, Jabbarov ND. Morphological study of mucous membrane of nasal cavity and diabetes mellitus. Bulletin of Otorhinolaryngology 1980;4:39-42 (In Russian).
18. Schaberg DS, Norwood JM. Case study: infections in diabetes mellitus. Diabetes Spectrum 2002 Jan;15(1):37-40.
19. Popov NN, Garyuk GI, Filatova IV, Ognivenko EV. Clinical and immunological feaatures of chronic purulent maxillary sinusitis in patients with diabetes mellitus. International Medical Journal 2007;(1):103-7 (In Russian).
20. Kitaygorodskiy AP. Positive effect of adenotonsillectomy in children suffering from chronic tonsillitis, adenoiditis and diabetes. Bulletin of Otorhinolaryngology 1984;(3):34-8 (In Russian).
21. Shishkova VN. Rational approach to solving cardiometabolic problems in treatment of comorbid patients. Vrach 2018;11:3-11 (In Russian).
22. Kremerman IB, Priimiagi LS, Kalvinsh IIa, Lukevits EIa. Interferon-inducing and antiinfluenzal properties of 3-(2,2,2-trimethylhydrazine)propionate in an experiment. Voprosy Virusologii 1987 Sep-Oct;32(5):576-9.
23. Safonova IS, Dadalova AI, Shuturova NYu. Effect of mildronate used as an adjuvant on immune human system. Experimental and Clinical Pharmacotherapy (Riga) 1992;20:67-71.
24. Kubar OI, Bryantseva EA, Davydova TV, Furgai SM, Bubenyova TV, Kolltygina NV. Results of clinical trials of mildronate immuno-adjuvant action in vaccination with inactivated influenza vaccine. Experimental and Clinical Pharmacotherapy (Riga) 1992;20:72-5.
25. Glozman VN, Berenbein BA, Kirmane RE, Pervushina NV, Shur AA, Agranovskii VB. Use of mildronate in therapy of seroresistant syphilis (serologic and immunologic comparisons). Antibiotiki i Khimioterapiya 1991;36:38-9.
26. Nikolaeva IA, Prokopenko LG. Immunomodulating action of energizing drugs during dosed fasting. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya 1998 Jul-Sep;3:12-5.
27. Starchenko AA, Khilko VA, Gaidar BV, Khlunovskii AN, Komarets SA. Characteristics of adaptive reactions of the body’s immune system following operations for vascular anomalies. NN Burdenko Journal of Neurosurgery1995;4:13-6.
28. Orlov VA, Sokolova VI, Zamotaev IP, Elagina LV, Zavolovskaia LI. Clinicoimmunologic aspects of using mildronate in patients with bronchopulmonary diseases. Antibiotiki i Khimioterapiya 1990;35:47-50.
29. Karashurov E, Ostrovskij A, Klavinsh I. Treatment of bronchial asthma with mildronate. Experimental and Clinical Pharmacotherapy (Riga) 1991;19:172-8.
30. Sakharchuk II, Ilnytskiy RI. The use of mildronate and trental in treating disorders of hemorheology and the intracardiac hemodynamics in patients with chronic obstructive bronchitis. Likarska Sprava 1996 Jan-Feb;1-2:122-5.
31.Antonenko LI, Frantsuzova SB, Arshinnikova LL. The effect of mildronate on erythrocyte membrane permeability in experimental lung pathology. Eksperimentalnaya i Klinicheskaya Farmakologiia 1992;55:33-5 (In Russian).
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]